Patents by Inventor Marilyn Fernandez

Marilyn Fernandez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HIV VPR-specific T-cell receptors
    Patent number: 10844107
    Abstract: The instant invention provides TCRs having one or more amino acid substitutions that bind to the AL9 epitope of the HIV protein vpr (AIIRILQQQL).
    Type: Grant
    Filed: July 25, 2017
    Date of Patent: November 24, 2020
    Assignee: ALTOR BIOSCIENCE, LLC
    Inventors: Marilyn Fernandez, Bai Liu, Warren Marcus, Hing C. Wong
  • HIV VPR-SPECIFIC T-CELL RECEPTORS
    Publication number: 20180148493
    Abstract: The instant invention provides TCRs having one or more amino acid substitutions that bind to the AL9 epitope of the HIV protein vpr (AIIRILQQQL).
    Type: Application
    Filed: July 25, 2017
    Publication date: May 31, 2018
    Inventors: Marilyn Fernandez, Bai Liu, Warren D. Marcus, Hing C. Wong
  • HIV vpr-specific T-cell receptors
    Patent number: 9714279
    Abstract: The instant invention provides TCRs having one or more amino acid substitutions that bind to the AL9 epitope of the HIV protein vpr (AIIRILQQQL).
    Type: Grant
    Filed: December 4, 2014
    Date of Patent: July 25, 2017
    Assignee: Altor Bioscience Corporation
    Inventors: Marilyn Fernandez, Bai Liu, Warren D. Marcus, Hing C. Wong
  • HIV VPR-SPECIFIC T-CELL RECEPTORS
    Publication number: 20150087059
    Abstract: The instant invention provides TCRs having one or more amino acid substitutions that bind to the AL9 epitope of the HIV protein vpr (AIIRILQQQL).
    Type: Application
    Filed: December 4, 2014
    Publication date: March 26, 2015
    Inventors: Marilyn Fernandez, Bai Liu, Warren D. Marcus, Hing C. Wong
  • HIV VPR-specific T cell receptors
    Patent number: 8933198
    Abstract: The instant invention provides TCRs having one or more amino acid substitutions that bind to the AL9 epitope of the HIV protein vpr (AIIRILQQL (SEQ ID NO: 1)).
    Type: Grant
    Filed: March 25, 2010
    Date of Patent: January 13, 2015
    Assignee: Altor BioScience Corporation
    Inventors: Marilyn Fernandez, Bai Liu, Warren D. Marcus, Hing C. Wong
  • HIV VPR-SPECIFIC T CELL RECEPTORS
    Publication number: 20100303829
    Abstract: The instant invention provides TCRs having one or more amino acid substitutions that bind to the AL9 epitope of the HIV protein vpr (AIIRILQQL (SEQ ID NO: 1)).
    Type: Application
    Filed: March 25, 2010
    Publication date: December 2, 2010
    Applicant: ALTOR BIOSCIENCE CORPORATION
    Inventors: Marilyn Fernandez, Bai Liu, Warren D. Marcus, Hing C. Wong